HCPCS Level II drug code
J0584 — Injection, burosumab-twza 1 mg
In short
J0584 is the HCPCS Level II code for injection, burosumab-twza 1 mg. CMS assigns NDCs for Crysvita to it. The Medicare Part B payment limit is $516.85 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, burosumab-twza 1 mg
- Short descriptor
- Injection, burosumab-twza 1m
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2019
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Inflation-adjusted coinsurance. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J0584
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 3 NDCs to J0584 for Crysvita. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Crysvita | 42747-0102-01 | Kyowa Kirin, Inc. | 1 | 10 |
| Crysvita | 42747-0203-01 | Kyowa Kirin, Inc. | 1 | 20 |
| Crysvita | 42747-0304-01 | Kyowa Kirin, Inc. | 1 | 30 |
J0584: common questions
- Is J0584 a CPT code?
- No. J0584 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J0584?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 3 NDCs under J0584, for Crysvita. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J0584?
- $516.85 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.